Results 31 to 40 of about 7,470 (208)
This study investigates the prescription of antimuscarinic medication and the opinions of qualified psychiatric nursing staff regarding the use of ‘as required’ antimuscarinic drugs at a large secure psychiatric unit.
Norman McClelland +2 more
core +1 more source
Urgency is the prevalent and most bothersome symptom of overactive bladder (OAB) and the treatment of urgency is the primary objective in the management of OAB.
Karl-Erik Andersson +6 more
doaj +1 more source
Purpose: To evaluate long-term antimuscarinic drug persistence and its associated characteristics in patients with overactive bladder (OAB) treated with antimuscarinic agents.
Chung-Cheng Wang, Hann-Chorng Kuo
doaj +1 more source
Objectives This network meta-analysis aimed to assess the safety profiles of seven commonly used oral antimuscarinic drugs (darifenacin, fesoterodine, imidafenacin, oxybutynin, propiverine, solifenacin, and tolterodine) in patients with overactive ...
Nannan Yang +3 more
doaj +1 more source
The aim of this study was to compare the effect of antimuscarinic antagonists on carbachol-induced contraction of normal human bladder and detrusor overactivity associated with benign prostatic hyperplasia (DO/BPH).
Tomonori Yamanishi +5 more
doaj +1 more source
Medical treatment of overactive bladder (OAB) includes antimuscarinic agents, beta-3 adrenoceptor agonist (mirabegron), or combination with both drugs. Recently, a meta-analysis reported the integrated clinical trial data from 10 phase 2–4, double-blind,
Hann-Chorng Kuo
doaj +1 more source
Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle
Objectives. To investigate the antimuscarinic effect of oxybutynin in the rat cletrusor muscle after estrogen pretreatment because, to our knowledge, no study has been done on the interaction of estrogen with antimuscarinic drugs. Estrogen has been shown
Kilciler, M +5 more
core +1 more source
Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial [PDF]
Background Antimuscarinic agents are currently the predominant treatment option for the clinical management of the symptoms of overactive bladder (OAB).
Vik Khullar +13 more
core +2 more sources
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah +4 more
wiley +1 more source
Abstract Background Lower urinary tract symptoms (LUTS) are among the most prevalent nonmotor complaints across the parkinsonian spectrum, yet they remain underutilized as diagnostic and management signals in neurology practice. Although prior reviews have characterized disease‐specific patterns of urinary dysfunction, and recent guidelines address ...
Saar Anis +3 more
wiley +1 more source

